Mycophenolate After Stem Cell Transplant for Systemic Sclerosis

NCT07734012 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis (SSc)

Interventions

DRUG: Mycophenolate Mofetil 1000 mg twice daily

Sponsor

Ottawa Hospital Research Institute

Collaborators

[object Object]